quindoxin has been researched along with Koch's Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goldman, RC | 1 |
| Aldana, I; Cho, SH; Franzblau, SG; Goldman, RC; Lenaerts, AJ; Maddry, JA; Monge, A; Pérez-Silanes, S; Solano, B; Vicente, E; Villar, R | 1 |
2 other study(ies) available for quindoxin and Koch's Disease
| Article | Year |
|---|---|
Maximizing bactericidal activity with combinations of bioreduced drugs.
Topics: Animals; Antitubercular Agents; Clinical Trials as Topic; Drug Combinations; Drug Discovery; Free Radicals; Humans; Mycobacterium tuberculosis; Nitrofurans; Nitroimidazoles; Oxidation-Reduction; Quinoxalines; Tuberculosis | 2010 |
In vitro and in vivo antimycobacterial activities of ketone and amide derivatives of quinoxaline 1,4-di-N-oxide.
Topics: Administration, Oral; Animals; Antitubercular Agents; Biotransformation; Drug Resistance, Multiple, Bacterial; Female; Mice; Microbial Sensitivity Tests; Microbial Viability; Molecular Structure; Mycobacterium tuberculosis; Quinoxalines; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2008 |